Letter to the editor
Jan 2018
SVR Reduced HCC by 71%
from Jules: there never was any doubt that SVR would reduce or eliminate risk for HCC. In this study cirrhosis prior to treatment had a higher HCC risk then for those without cirrhosis, but that is to be expected and merely reinforces how crucial it is to treat HCV as early as possible...
Full Text
from Jules: there never was any doubt that SVR would reduce or eliminate risk for HCC. In this study cirrhosis prior to treatment had a higher HCC risk then for those without cirrhosis, but that is to be expected and merely reinforces how crucial it is to treat HCV as early as possible...
Full Text
Direct-acting antiviral treatment for hepatitis C did not correlate with an increased risk for hepatocellular carcinoma in a large cohort study of both treated and untreated patients with or without cirrhosis. Those with incident HCC after DAA treatment had higher risk factors at baseline.
Dec 2016
Healio
The following articles appeared in the December print edition of HCV NEXT, published online at Healio.
Cover Story
Screening for HCC in the Post-SVR12 Setting
Screening for HCC in the Post-SVR12 Setting
The Take Home
The Liver Meeting 2016
Infectious Disease Week 2016
The Liver Meeting 2016: Beyond HCV
The Liver Meeting 2016
Infectious Disease Week 2016
The Liver Meeting 2016: Beyond HCV
No comments:
Post a Comment